Bivalirudin

Grade: Pharmaceutical Grade

Factory Location: Wuhan, China

Main Sales Markets: North America

Sample Provided: no

Payment Terms: L/C

Indications:

• As an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
• In patients undergoing percutaneous coronary intervention (PCI).
• For use in patients with, or at risk for, heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS).